Works by van Raalte, Daniel H.

Results: 90

SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management.

Published in:

2018

By:

van Baar, Michael J. B.;
van Ruiten, Charlotte C.;
Muskiet, Marcel H. A.;
van Bloemendaal, Liselotte;
IJzerman, Richard G.;
van Raalte, Daniel H.;
van Baar, Michaël J B;
van Raalte, Daniël H

Publication type:

journal article

Effects of dapagliflozin on sodium excretion, blood pressure and volume status in patients with type 2 diabetes and/or chronic kidney disease: The DAPASALT trial.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 8, p. 4415, doi. 10.1111/dom.16478

By:

Beernink, Jelle M.;
Jongs, Niels;
Mosterd, Charlotte M.;
Scholtes, Rosalie A.;
Caldwell‐McGee, Alyssa;
Casillas, Daniel;
Driscoll, Lynette;
Greasley, Peter J.;
Karlsson, Cecilia;
Hammarstedt, Ann;
Sridhar, Vikas S.;
Muskiet, Marcel H. A.;
Laverman, Gozewijn D.;
Cherney, David Z. I.;
Bjornstad, Petter;
van Raalte, Daniel H.;
Heerspink, Hiddo J. L.

Publication type:

Article

Effects of sodium-glucose transporter-2 inhibition on systemic hemodynamics, renal function, and intra-renal oxygenation in sepsis-associated acute kidney injury.

Published in:

Intensive Care Medicine Experimental, 2024, v. 12, n. 1, p. 1, doi. 10.1186/s40635-024-00647-2

By:

Hulst, Abraham H.;
Ow, Connie P. C.;
May, Clive N.;
Hood, Sally H.;
Plummer, Mark P.;
Hermanides, Jeroen;
van Raalte, Daniël H.;
Deane, Adam M.;
Bellomo, Rinaldo;
Lankadeva, Yugeesh R.

Publication type:

Article

Fasting and postprandial kidney haemodynamic effects of empagliflozin and linagliptin in mono‐ and combination therapy compared to gliclazide in overweight people with type 2 diabetes (RACELINES): A randomised, double‐blind trial.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 7, p. 3943, doi. 10.1111/dom.16431

By:

van Baar, Michaël J. B.;
Muskiet, Marcel H. A.;
Scholtes, Rosalie A.;
Touw, Daan J.;
Nieuwdorp, Max;
Kramer, Mark H. H.;
Joles, Jaap A.;
Cherney, David Z. I.;
Bjornstad, Petter;
Krebber, Merle M.;
van Raalte, Daniël H.

Publication type:

Article

Effect of tirzepatide on blood pressure and lipids: A meta‐analysis of randomized controlled trials.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 12, p. 3766, doi. 10.1111/dom.15272

By:

Kanbay, Mehmet;
Copur, Sidar;
Siriopol, Dimitrie;
Yildiz, Abdullah Burak;
Gaipov, Abduzhappar;
van Raalte, Daniel H.;
Tuttle, Katherine R.

Publication type:

Article

Albuminuria‐lowering effect of dapagliflozin, exenatide, and their combination in patients with type 2 diabetes: A randomized cross‐over clinical study.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1758, doi. 10.1111/dom.15033

By:

van der Aart‐van der Beek, Annemarie B.;
Apperloo, Ellen;
Jongs, Niels;
Rouw, Dennis B.;
Sjöström, C. David;
Friedli, Iris;
Johansson, Lars;
van Raalte, Daniël H.;
Hoogenberg, Klaas;
Heerspink, Hiddo J. L.

Publication type:

Article

Mechanisms underlying the blood pressure‐lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes: A secondary analysis of a randomized crossover trial.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 1, p. 198, doi. 10.1111/dom.14864

By:

Scholtes, Rosalie A.;
Mosterd, Charlotte M.;
Hesp, Anne C.;
Smits, Mark M.;
Heerspink, Hiddo J. L.;
van Raalte, Daniël H.

Publication type:

Article

Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes: Results from DAPASALT and DIAMOND.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 8, p. 1578, doi. 10.1111/dom.14729

By:

Sen, Taha;
Scholtes, Rosalie;
Greasley, Peter J.;
Cherney, David Z. I.;
Dekkers, Claire C. J.;
Vervloet, Marc;
Danser, Alexander H. J.;
Barbour, Sean J.;
Karlsson, Cecilia;
Hammarstedt, Ann;
Li, Qiang;
Laverman, Gozewijn D.;
Bjornstad, Petter;
van Raalte, Daniel H.;
Heerspink, Hiddo J. L.

Publication type:

Article

Postprandial renal haemodynamic effects of the dipeptidyl peptidase‐4 inhibitor linagliptin versus the sulphonylurea glimepiride in adults with type 2 diabetes (RENALIS): A predefined substudy of a randomized, double‐blind trial.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 1, p. 115, doi. 10.1111/dom.14557

By:

Muskiet, Marcel H. A.;
Tonneijck, Lennart;
Smits, Mark M.;
Kramer, Mark H. H.;
Ouwens, D. Margriet;
Hartmann, Bolette;
Holst, Jens J.;
Danser, A. H. Jan;
Joles, Jaap A.;
van Raalte, Daniël H.

Publication type:

Article

Iloprost infusion prevents the insulin‐induced reduction in skeletal muscle microvascular blood volume but does not enhance peripheral glucose uptake in type 2 diabetic patients.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 11, p. 2523, doi. 10.1111/dom.13410

By:

Emanuel, Anna L.;
de Clercq, Nicolien C.;
Koopen, Annefleur M.;
van Poelgeest, Erik;
Serlie, Mireille J. M.;
van Raalte, Daniel H.;
Kramer, Mark H. H.;
Nieuwdorp, Max;
Eringa, Etto C.;
Serné, Erik H.

Publication type:

Article

Effect of immediate and prolonged GLP‐1 receptor agonist administration on uric acid and kidney clearance: <italic>Post‐hoc</italic> analyses of four clinical trials.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 5, p. 1235, doi. 10.1111/dom.13223

By:

Tonneijck, Lennart;
Muskiet, Marcel H. A.;
Smits, Mark M.;
Kramer, Mark H. H.;
Diamant, Michaela;
van Raalte, Daniël H.;
Bjornstad, Petter;
Hoorn, Ewout J.;
Joles, Jaap A.

Publication type:

Article

Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: An 8-week, randomised, open-label trial.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 12, p. 1669, doi. 10.1111/dom.12985

By:

Tonneijck, Lennart;
Muskiet, Marcel H. A.;
Smits, Mark M.;
Hoekstra, Trynke;
Kramer, Mark H. H.;
Danser, A. H. Jan;
Diamant, Michaela;
Joles, Jaap A.;
van Raalte, Daniël H.

Publication type:

Article

Improving glycaemic control in type 2 diabetes: Stimulate insulin secretion or provide beta-cell rest?

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 9, p. 1205, doi. 10.1111/dom.12935

By:

van Raalte, Daniël H.;
Verchere, C. Bruce

Publication type:

Article

Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients.

Published in:

Diabetes, Obesity & Metabolism, 2016, v. 18, n. 12, p. 1217, doi. 10.1111/dom.12748

By:

Smits, Mark M.;
Tonneijck, Lennart;
Muskiet, Marcel H.A.;
Hoekstra, Trynke;
Kramer, Mark H.H.;
Diamant, Michaela;
Nieuwdorp, Max;
Groen, Albert K.;
Cahen, Djuna L.;
van Raalte, Daniël H.

Publication type:

Article

Skin microvascular function and renal hemodynamics in overweight patients with type 2 diabetes: A cross‐sectional study.

Published in:

Microcirculation, 2021, v. 28, n. 6, p. 1, doi. 10.1111/micc.12700

By:

Bouman, Emma J.;
Smits, Mark M.;
van Bommel, Erik J.;
Muskiet, Marcel H. A.;
Hesp, Anne C.;
Serné, Erik H.;
Joles, Jaap A.;
van Raalte, Daniël H.

Publication type:

Article

Assessment of real‐time and quantitative changes in renal hemodynamics in healthy overweight males: Contrast‐enhanced ultrasonography vs para‐aminohippuric acid clearance.

Published in:

Microcirculation, 2019, v. 26, n. 7, p. N.PAG, doi. 10.1111/micc.12580

By:

Muskiet, Marcel H. A.;
Emanuel, Anna L.;
Smits, Mark M.;
Tonneijck, Lennart;
Meijer, Rick I.;
Joles, Jaap A.;
Serné, Erik H.;
van Raalte, Daniël H.

Publication type:

Article

The incretin pathway as a therapeutic target in diabetic kidney disease: a clinical focus on GLP-1 receptor agonists.

Published in:

Therapeutic Advances in Endocrinology & Metabolism, 2019, v. 10, p. 1, doi. 10.1177/2042018819865398

By:

van Baar, Michaël J. B.;
van der Aart, Annemarie B.;
Hoogenberg, Klaas;
Joles, Jaap A.;
Heerspink, Hiddo J. L.;
van Raalte, Daniël H.

Publication type:

Article

The incretin pathway as a therapeutic target in diabetic kidney disease: a clinical focus on GLP-1 receptor agonists.

Published in:

Therapeutic Advances in Endocrinology & Metabolism, 2019, v. 10, p. 1, doi. 10.1177/2042018819865398

By:

van Baar, Michaël J. B.;
van der Aart, Annemarie B.;
Hoogenberg, Klaas;
Joles, Jaap A.;
Heerspink, Hiddo J. L.;
van Raalte, Daniël H.

Publication type:

Article

Mechanisms underlying the blood pressure lowering effects of dapagliflozin, exenatide, and their combination in people with type 2 diabetes: a secondary analysis of a randomized trial.

Published in:

Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01492-x

By:

van Ruiten, Charlotte C.;
Smits, Mark M.;
Kok, Megan D.;
Serné, Erik H.;
van Raalte, Daniël H.;
Kramer, Mark H. H.;
Nieuwdorp, Max;
IJzerman, Richard G.

Publication type:

Article

Role of sodium-glucose cotransporter 2 inhibition to mitigate diabetic kidney disease risk in type 1 diabetes.

Published in:

Nephrology Dialysis Transplantation, 2020, v. 35, p. i24, doi. 10.1093/ndt/gfz228

By:

Raalte, Daniël H van;
Bjornstad, Petter

Publication type:

Article

Hoge vezelinname en lage koolhydraatinname geassocieerd met betere time in range bij patiënten met type 1-diabetes in een cross-sectionele studie: Hoge vezelinname en lage koolhydraatinname geassocieerd met betere time in range bij patiënten met type 1-diabetes in een cross-sectionele studie

Published in:

Nederlands Tijdschrift voor Diabetologie (NTvD), 2025, v. 23, n. 1, p. 6, doi. 10.1007/s12467-025-1580-4

By:

de Wit, Douwe F.;
Fuhri Snethlage, Coco M.;
Rampanelli, Elena;
Maasen, Kim;
Walpot, Noortje;
van Raalte, Daniël H.;
Nieuwdorp, Max;
Soeters, Maarten R.;
Hanssen, Nordin M.J.

Publication type:

Article

The gut microbiome is associated with residual β-cell function and glycemic control in type 1 diabetes.

Published in:

Nederlands Tijdschrift voor Diabetologie (NTvD), 2023, v. 21, n. 4, p. 46

By:

Fuhri Snethlage, Coco M.;
Davids, Mark;
Rampanelli, Elena;
de Groen, Pleun;
Verdoes, Xanthe;
Herrema, Hilde J.;
van Raalte, Daniël H.;
Roep, Bart O.;
Nieuwdorp, Max;
Hanssen, Nordin M. J.

Publication type:

Article

Exploring Kidney Oxygenation Responses to Dapagliflozin, Exenatide, and Their Combination in Patients With Type 2 Diabetes and Chronic Kidney Disease: Observations From a Prespecified Pilot Study of a Randomized Crossover Trial.

Published in:

2025

By:

Apperloo, Ellen M.;
Heerspink, Hiddo J.L.;
van der Aart, Annemarie B.;
Rouw, Dennis;
van Raalte, Daniël H.;
Hoogenberg, Klaas;
Jongs, Niels;
Muskiet, Marcel H.A.

Publication type:

Letter

Residual β-Cell Function Is Associated With Longer Time in Range in Individuals With Type 1 Diabetes.

Published in:

Diabetes Care, 2024, v. 47, n. 7, p. 1114, doi. 10.2337/dc23-0776

By:

Fuhri Snethlage, Coco M.;
McDonald, Timothy J.;
Oram, Richard D.;
de Groen, Pleun;
Rampanelli, Elena;
Schimmel, Alinda W. M.;
Holleman, Frits;
Siegelaar, Sarah;
Hoekstra, Joost;
Brouwer, Catherine B.;
Knop, Filip K.;
Verchere, C. Bruce;
van Raalte, Daniël H.;
Roep, Bart O.;
Nieuwdorp, Max;
Hanssen, Nordin M. J.

Publication type:

Article

Insulin Secretion, Sensitivity, and Kidney Function in Young Individuals With Type 2 Diabetes.

Published in:

Diabetes Care, 2024, v. 47, n. 3, p. 409, doi. 10.2337/dc23-1818

By:

Bjornstad, Petter;
Choi, Ye Ji;
Platnick, Carson;
Gross, Susan;
Narongkiatikhun, Phoom;
Melena, Isabella;
Remmers, Lauryn;
Baca, Madison;
Schutte, Grant;
Dobbs, Tyler;
Vigers, Tim;
Pyle, Laura;
Driscoll, Lynette;
Tommerdahl, Kalie;
Kendrick, Jessica;
Looker, Helen C.;
Dart, Allison;
Cherney, David;
van Raalte, Daniel H.;
Srivastava, Anand

Publication type:

Article

Age Ain't Nothing But a Number... or Is It?

Published in:

Diabetes Care, 2023, v. 46, n. 6, p. 1135, doi. 10.2337/dci23-0013

By:

Redondo, Maria J.;
van Raalte, Daniël H.

Publication type:

Article

Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390.

Published in:

2023

By:

Smits, Mark M.;
van Raalte, Daniël H.

Publication type:

Letter to the Editor

Differences in Body Composition Convey a Similar Risk of Type 2 Diabetes Among Different Ethnic Groups With Disparate Cardiometabolic Risk-The HELIUS Study.

Published in:

2021

By:

Zethof, Marleen;
Mosterd, Charlotte M.;
Collard, Didier;
Galenkamp, Henrike;
Agyemang, Charles;
Nieuwdorp, Max;
van Raalte, Daniël H.;
van den Born, Bert-Jan H.

Publication type:

journal article

Natriuretic Effect of Two Weeks of Dapagliflozin Treatment in Patients With Type 2 Diabetes and Preserved Kidney Function During Standardized Sodium Intake: Results of the DAPASALT Trial.

Published in:

2021

By:

Scholtes, Rosalie A.;
Muskiet, Marcel H.A.;
van Baar, Michiel J.B.;
Hesp, Anne C.;
Greasley, Peter J.;
Karlsson, Cecilia;
Hammarstedt, Ann;
Arya, Niki;
van Raalte, Daniël H.;
Heerspink, Hiddo J.L.

Publication type:

journal article

Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride as Add-on to Metformin on Renal Physiology in Overweight Patients With Type 2 Diabetes (RENALIS): A Randomized, Double-Blind Trial.

Published in:

2020

By:

Muskiet, Marcel H.A.;
Tonneijck, Lennart;
Smits, Mark M.;
Kramer, Mark H.H.;
Ouwens, D. Margriet;
Hartmann, Bolette;
Holst, Jens J.;
Touw, Daan J.;
Danser, A.H. Jan;
Joles, Jaap A.;
van Raalte, Daniël H.

Publication type:

journal article

Insulin Sensitivity and Renal Hemodynamic Function in Metformin-Treated Adults With Type 2 Diabetes and Preserved Renal Function.

Published in:

Diabetes Care, 2020, v. 43, n. 1, p. 228, doi. 10.2337/dc19-1651

By:

van Bommel, Erik J. M.;
Ruiter, Danique;
Muskiet, Marcel H. A.;
van Baar, Michaël J. B.;
Kramer, Mark H. H.;
Nieuwdorp, Max;
Joles, Jaap A.;
Bjornstad, Petter;
van Raalte, Daniël H.

Publication type:

Article

Sleep and HbA<sub>1c</sub> in Patients With Type 2 Diabetes: Which Sleep Characteristics Matter Most?

Published in:

2020

By:

Brouwer, Annelies;
van Raalte, Daniel H.;
Rutters, Femke;
Elders, Petra J. M.;
Snoek, Frank J.;
Beekman, Aartjan T. F.;
Bremmer, Marijke A.

Publication type:

journal article

Erratum. SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management. Diabetes Care 2018;41:1543-1556.

Published in:

2019

By:

van Baar, Michaël J B;
van Ruiten, Charlotte C;
Muskiet, Marcel H A;
van Bloemendaal, Liselotte;
IJzerman, Richard G;
van Raalte, Daniël H

Publication type:

Journal Article

The Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 Diabetes.

Published in:

Diabetes Care, 2019, v. 42, n. 10, p. 1921, doi. 10.2337/dc19-0937

By:

van Raalte, Daniël H.;
Bjornstad, Petter;
Persson, Frederik;
Powell, David R.;
de Cassia Castro, Rita;
Wang, Ping Stella;
Minzhi Liu;
Heerspink, Hiddo J. L.;
Cherney, David

Publication type:

Article

The Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 Diabetes.

Published in:

2019

By:

van Raalte, Daniël H;
Bjornstad, Petter;
Persson, Frederik;
Powell, David R;
de Cassia Castro, Rita;
Wang, Ping Stella;
Liu, Minzhi;
Heerspink, Hiddo J L;
Cherney, David

Publication type:

journal article

Effects of Light Therapy on Mood and Insulin Sensitivity in Patients With Type 2 Diabetes and Depression: Results From a Randomized Placebo-Controlled Trial.

Published in:

2019

By:

Brouwer, Annelies;
van Raalte, Daniel H.;
Hoang-Ton Nguyen;
Rutters, Femke;
van de Ven, Peter M.;
Elders, Petra J. M.;
Moll, Annette C.;
Van Someren, Eus J. W.;
Snoek, Frank J.;
Beekman, Aartjan T. F.;
Bremmer, Marijke A.;
Nguyen, Hoang-Ton

Publication type:

journal article

Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39:2042-2050.

Published in:

2019

By:

Tonneijck, Lennart;
Smits, Mark M;
Muskiet, Marcel H A;
Hoekstra, Trynke;
Kramer, Mark H H;
Danser, A H Jan;
Ter Wee, Piet M;
Diamant, Michaela;
Joles, Jaap A;
van Raalte, Daniel H

Publication type:

journal article

Comment on Lovshin et al. Dipeptidyl Peptidase 4 Inhibition Stimulates Distal Tubular Natriuresis and Increases in Circulating SDF-1α<sup>1-67</sup> in Patients With Type 2 Diabetes. Diabetes Care 2017;40:1073-1081.

Published in:

2017

By:

van Baar, Michaël J. B.;
van Raalte, Daniël H.;
Muskiet, Marcel H. A.

Publication type:

Letter

Pancreatic Effects of Liraglutide or Sitagliptin in Overweight Patients With Type 2 Diabetes: A 12-Week Randomized, Placebo-Controlled Trial.

Published in:

2017

By:

Smits, Mark M.;
Tonneijck, Lennart;
Muskiet, Marcel H. A.;
Kramer, Mark H. H.;
Pieters-van den Bos, Indra C.;
Vendrik, Karuna E. W.;
Hoekstra, Trynke;
Bruno, Marco J.;
Diamant, Michaela;
van Raalte, Daniël H.;
Cahen, Djuna L.

Publication type:

journal article

Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.

Published in:

2016

By:

Tonneijck, Lennart;
Smits, Mark M.;
Muskiet, Marcel H. A.;
Hoekstra, Trynke;
Kramer, Mark H. H.;
Danser, A. H. Jan;
ter Wee, Piet M.;
Diamant, Michaela;
Joles, Jaap A.;
van Raalte, Daniël H.

Publication type:

journal article

Effect of 3 Years of Treatment With Exenatide on Postprandial Glucagon Levels.

Published in:

2016

By:

Smits, Mark M.;
Bunck, Mathijs C.;
Diamant, Michaela;
Corner, Anja;
Eliasson, Bjorn;
Heine, Robert J.;
Smith, Ulf;
Yki-Järvinen, Hannele;
van Raalte, Daniël H.

Publication type:

Letter

Comment on Thomsen et al. Incretin-Based Therapy and Risk of Acute Pancreatitis: A Nationwide Population-Based Case-Control Study. Diabetes Care 2015;38:1089-1098.

Published in:

2015

By:

Smits, Mark M;
Muskiet, Marcel H A;
Tonneijck, Lennart;
van Raalte, Daniël H

Publication type:

Letter

Incretin-Based Therapy and Risk of Acute Pancreatitis: A Nationwide Population-Based Case-Control Study. Diabetes Care 2015;38:1089-1098.

Published in:

2015

By:

Smits, Mark M.;
Muskiet, Marcel H. A.;
Tonneijck, Lennart;
van Raalte, Daniel H.

Publication type:

Opinion

Metabolite Profile of Treatment-Naive Metabolic Syndrome Subjects in Relation to Cardiovascular Disease Risk.

Published in:

Metabolites (2218-1989), 2021, v. 11, n. 4, p. 236, doi. 10.3390/metabo11040236

By:

Warmbrunn, Moritz V.;
Koopen, Annefleur M.;
de Clercq, Nicolien C.;
de Groot, Pieter F.;
Kootte, Ruud S.;
Bouter, Kristien E. C.;
ter Horst, Kasper W.;
Hartstra, Annick V.;
Serlie, Mireille J.;
Ackermans, Mariette T.;
Soeters, Maarten R.;
van Raalte, Daniel H.;
Davids, Mark;
Nieuwdorp, Max;
Groen, Albert K.

Publication type:

Article

Exposure–Response Analysis of the Sodium–Glucose Cotransporter-2 Inhibitors Dapagliflozin and Empagliflozin on Kidney Hemodynamics in Patients with Type 2 Diabetes.

Published in:

Journal of Personalized Medicine, 2023, v. 13, n. 5, p. 747, doi. 10.3390/jpm13050747

By:

van der Hoek, Sjoukje;
Koomen, Jeroen V.;
van Bommel, Erik J. M.;
Mosterd, Charlotte M.;
Scholtes, Rosalie A.;
Hesp, Anne C.;
Stevens, Jasper;
van Raalte, Daniel H.;
Heerspink, Hiddo J. L.

Publication type:

Article

Networks of gut bacteria relate to cardiovascular disease in a multi-ethnic population: the HELIUS study.

Published in:

Cardiovascular Research, 2024, v. 120, n. 4, p. 372, doi. 10.1093/cvr/cvae018

By:

Warmbrunn, Moritz V;
Boulund, Ulrika;
Aron-Wisnewsky, Judith;
Goffau, Marcus C de;
Abeka, Rosamel E;
Davids, Mark;
Bresser, Lucas R F;
Levin, Evgeni;
Clement, Karine;
Galenkamp, Henrike;
Ferwerda, Bart;
Born, Bert-Jan J H van den;
Kurilshikov, Alexander;
Fu, Jingyuan;
Zwinderman, Aeilko H;
Soeters, Maarten R;
Raalte, Daniel H van;
Herrema, Hilde;
Groen, Albert K;
Nieuwdorp, Max

Publication type:

Article

Cardiovascular effects of glucagon-like peptide 1 receptor agonists: from mechanistic studies in humans to clinical outcomes.

Published in:

Cardiovascular Research, 2020, v. 116, n. 5, p. 916, doi. 10.1093/cvr/cvz323

By:

Heuvelman, Valerie D;
Raalte, Daniël H Van;
Smits, Mark M

Publication type:

Article

Glucagon-like peptide-1 receptor agonist treatment prevents glucocorticoid-induced glucose intolerance and islet-cell dysfunction in humans.

Published in:

2011

By:

van Raalte DH;
van Genugten RE;
Linssen MM;
Ouwens DM;
Diamant M;
van Raalte, Daniël H;
van Genugten, Renate E;
Linssen, Margot M L;
Ouwens, D Margriet;
Diamant, Michaela

Publication type:

journal article

Glucagon-Like Peptide. 1 Receptor Agonist Treatment Prevents Glucocorticoid-Induced Glucose Intolerance and Islet-Cell Dysfunction in Humans.

Published in:

Diabetes Care, 2011, v. 34, n. 2, p. 412, doi. 10.2337/dc10-1677

By:

VAN RAALTE, DANIËL H.;
VAN GENUGTEN, RENATE E.;
LINSSEN, MARGOT M. L.;
OUWENS, D. MARGRIET;
DIAMANT, MICHAELA

Publication type:

Article

FHL2 Genetic Polymorphisms and Pro-Diabetogenic Lipid Profile in the Multiethnic HELIUS Cohort.

Published in:

International Journal of Molecular Sciences, 2023, v. 24, n. 5, p. 4332, doi. 10.3390/ijms24054332

By:

Habibe, Jayron J.;
Boulund, Ulrika;
Clemente-Olivo, Maria P.;
de Vries, Carlie J. M.;
Eringa, Etto C.;
Nieuwdorp, Max;
Ferwerda, Bart;
Zwinderman, Koos;
van den Born, Bert-Jan H.;
Galenkamp, Henrike;
van Raalte, Daniel H.

Publication type:

Article